Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1475

1.

Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.

Tiews S, Steinberg W, Schneider W, Hanrath C.

J Clin Virol. 2009 Nov;46 Suppl 3:S11-5. doi: 10.1016/S1386-6532(09)70295-1.

PMID:
20129068
[PubMed - indexed for MEDLINE]
2.

Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.

Luyten A, Scherbring S, Reinecke-Lüthge A, Braun BE, Pietralla M, Theiler K, Petry KU.

J Clin Virol. 2009 Nov;46 Suppl 3:S5-10. doi: 10.1016/S1386-6532(09)70294-X.

PMID:
20129072
[PubMed - indexed for MEDLINE]
3.

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.

J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.

PMID:
19903804
[PubMed - indexed for MEDLINE]
Free Article
4.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

PMID:
16978225
[PubMed - indexed for MEDLINE]
5.

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.

Denise Zielinski G, Snijders PJ, Rozendaal L, Voorhorst FJ, Runsink AP, de Schipper FA, Meijer CJ.

J Pathol. 2001 Oct;195(3):300-6.

PMID:
11673826
[PubMed - indexed for MEDLINE]
6.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

PMID:
12509400
[PubMed - indexed for MEDLINE]
Free Article
7.

[Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].

Guo YL, You K, Geng L, Zhang XW, Shen XY, Yao YJ, Fan XH.

Beijing Da Xue Xue Bao. 2006 Oct 18;38(5):480-2. Chinese.

PMID:
17068618
[PubMed - indexed for MEDLINE]
Free Article
8.

The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population.

Inoue M, Sakaguchi J, Sasagawa T, Tango M.

Int J Gynecol Cancer. 2006 May-Jun;16(3):1007-13.

PMID:
16803477
[PubMed - indexed for MEDLINE]
9.

[Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].

Qian DY, Cen JM, Wang D, Zeng RH, Lin AH, Shu YH, Hong DH, Huang ZH.

Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):34-7. Chinese.

PMID:
16635326
[PubMed - indexed for MEDLINE]
10.

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.

Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P.

Obstet Gynecol. 2007 Jun;109(6):1325-31.

PMID:
17540804
[PubMed - indexed for MEDLINE]
11.

New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.

Syrjänen K.

Eur J Gynaecol Oncol. 2008;29(3):205-21.

PMID:
18592782
[PubMed - indexed for MEDLINE]
12.

Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.

Wong AK, Chan RC, Nichols WS, Bose S.

Cancer. 2009 Feb 15;115(4):823-32. doi: 10.1002/cncr.24091.

PMID:
19127558
[PubMed - indexed for MEDLINE]
Free Article
13.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.

Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J; Morelos HPV Study Collaborators.

Salud Publica Mex. 2002 Jul-Aug;44(4):335-44.

PMID:
12216521
[PubMed - indexed for MEDLINE]
14.

Validation of high-risk HPV tests for primary cervical screening.

Meijer CJ, Berkhof H, Heideman DA, Hesselink AT, Snijders PJ.

J Clin Virol. 2009 Nov;46 Suppl 3:S1-4. doi: 10.1016/S1386-6532(09)00540-X.

PMID:
20129067
[PubMed - indexed for MEDLINE]
15.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

PMID:
10507785
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.

Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang HJ, Law KS.

J Reprod Med. 2000 Apr;45(4):345-50.

PMID:
10804494
[PubMed - indexed for MEDLINE]
17.

[Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].

Bekkers RL, Hanselaar AG, Melchers WJ, van Schaik JH, Boonstra H, Massuger LF.

Ned Tijdschr Geneeskd. 2003 Feb 15;147(7):302-6. Dutch.

PMID:
12622008
[PubMed - indexed for MEDLINE]
18.

Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.

Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.

Cancer. 2006 Mar 1;106(5):1054-64.

PMID:
16421920
[PubMed - indexed for MEDLINE]
Free Article
19.

The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.

Cox JT; American Society for Colposcopy and Cervical Pathology.

Arch Pathol Lab Med. 2003 Aug;127(8):950-8.

PMID:
12952506
[PubMed - indexed for MEDLINE]
20.

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.

J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9.

PMID:
16030305
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk